Congratulations to Dr. Enrico Novelli who, with former VMI colleague Dr. Carolyn Anderson, was recently awarded a new NHLBI R01 titled, “PET Imaging of Vaso-Occlusive Crisis in Sickle Cell Disease.”
Dr. Kaufman was recently awarded a new NIH-NICHD R21 titled, “Developing intrabody therapeutics for mitochondrial DNA heteroplasmy.”
Dr. Shiva’s new study aims to understand the role of mitochondrial function in age-associated physical function decline.
Dr. Pradhan-Sundd received an ASH Scholar Award – one of ASH’s most prestigious award programs for junior faculty dedicating a career to hematology research.
Dr. Ofori-Acquah’s new study aims to develop a new and specific treatment for acute chest syndrome (ACS) for both children and adult patients.
The VMI Pilot Project Program in Hemostasis and Vascular Biology (P3HVB) will support grants of $25,000 for one year duration. Applications for new projects may request up to $50,000 with appropriate justification.
Submit your proposal by April 15!
Calling all minority undergraduate students interested in STEM! PURDIP is a paid, hands-on summer training program that is hosted by the Department of Medicine’s Vascular Medicine Institute (VMI). Applications are open for 2022!
Congratulations to Dr. Kang Kim who was recently awarded a new NHLBI R01. Dr. Kim has been awarded annual direct costs of nearly $500,000 for his grant titled, “Super Resolution Ultrasound Imaging of Vasa Vasorum to Characterize the Progression of Atherosclerotic...
Dr. Adam Straub was recently awarded a new NHLBI R35 titled, “Basic and Translational Studies in Redox Regulation of Cardiovascular Physiology and Disease.”
Dr. Iain Scott was recently awarded a new NIH-NHLBI R01 titled, “Fatty acid oxidation in female cardioprotection.”
The Department of Medicine will increase infrastructure and support for its PostDoctoral fellows. The VMI’s Dr. Iain Scott, PhD, and Dr. Sruti Shiva, PhD, will direct and oversee a new PostDoctoral Training Program (PDTP) that builds and amplifies on many of the Department’s existing career development programs.
Published in Science Advances, the study used a new algorithm to identify candidate cancer drugs for PH. The findings support broader use of this drug-repurposing platform for other non-cancerous conditions.
Congratulations to Dr. Partha Dutta who, with co-PI Dr. Radhika Muzumdar, was recently awarded a new NIH-NIA R01 titled, “Cardioprotective Role of Humanin in Aging.”
Prithu Sundd, PhD, has received the Basic Research Award from the Bayer Hemophilia Awards Program to identify the mechanism underlying joint-damage in hemophilia.
Congratulations to Dr. Steve Chan who was recently awarded a new NHLBI R01 titled, “Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertension.”
Not to boast, but we think our postdocs and junior faculty are pretty amazing!
The Vascular Medicine Institute and Section of Benign Hematology are pleased to announce the addition of Yvette Yien, PhD, to our research community starting August 1, 2021.
Congratulations to Dr. Adam Straub who, with former VMI colleague Dr. Eric Kelley, was recently awarded a new NHLBI R01 titled, “Role of Xanthine Oxidase in Heme-induced Vascular Dysfunction.”
We are pleased to announce the addition of Dr. Mohamed Trebak to our research community. Joining us from Penn State University, Dr. Trebak will move his laboratory to the University of Pittsburgh starting July 1, 2021.
On International Women’s Day, and every day, we recognize the exceptional women faculty and staff of the VMI. In a particularly challenging year, our women leaders, researchers, trainees, and admins have overcome significant obstacles to do the work we value here.